Searcharxiv⌕ Search

arXiv subjects

Thomas M. Berghaus

Publications and source records attributed to Thomas M. Berghaus.

2 recordsLinked to original sources

CoughPhase-CLR: Designing an acoustics-informed foundation model for coughing sound classification

In this work, we introduce CoughPhase-CLR, a self-supervised learning framework designed to leverage the physiological phases of a cough for robust representation learning. Unlike generic contrastive frameworks, CoughPhase-CLR constructs positive pairs based on these specific acoustic phases. We pre-trained our model on approximately 40 hours of public cough audio and evaluated it across five downstream tasks, including COVID-19 detection, chronic obstructive pulmonary disease (COPD) state classification, and smoker status prediction. Our results demonstrate that cough-specific pre-training consistently outperforms standard random-cropping techniques when training on cough recordings. Additionally, we benchmarked a diverse set of state-of-the-art models on COPD state classification, highlighting the difficulty of this task. The best-performing models, pretrained on either general audio or respiratory sounds, achieved a UAR of 57\%, failing to outperform the state-of-the-art performance of 84\% UAR achieved using speech analysis.

cs.SD↗

Distinguishing between pre- and post-treatment in the speech of patients with chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD) causes lung inflammation and airflow blockage leading to a variety of respiratory symptoms; it is also a leading cause of death and affects millions of individuals around the world. Patients often require treatment and hospitalisation, while no cure is currently available. As COPD predominantly affects the respiratory system, speech and non-linguistic vocalisations present a major avenue for measuring the effect of treatment. In this work, we present results on a new COPD dataset of 20 patients, showing that, by employing personalisation through speaker-level feature normalisation, we can distinguish between pre- and post-treatment speech with an unweighted average recall (UAR) of up to 82\,\% in (nested) leave-one-speaker-out cross-validation. We further identify the most important features and link them to pathological voice properties, thus enabling an auditory interpretation of treatment effects. Monitoring tools based on such approaches may help objectivise the clinical status of COPD patients and facilitate personalised treatment plans.

cs.SD↗